PIRS

Pieris Pharmaceuticals (PIRS)

Pieris Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PIRS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	05:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2024/05/09	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2024/02/15	06:37	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2024/02/15	03:12	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2024/02/14	23:19	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2024/02/02	23:59	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/12/22	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/11/15	06:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/09/01	05:15	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/08/11	06:04	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/08/11	05:24	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/07/18	22:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/07/13	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/27	06:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/24	05:47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/24	05:47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/24	05:47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/24	05:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/24	05:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/21	20:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/12	19:43	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/06/08	19:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/05/31	05:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/05/23	06:01	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/05/20	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/05/11	19:02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/05/10	20:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/04/29	05:22	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/04/29	05:20	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc
2023/04/01	05:05	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PIRS	Pieris Pharmaceuticals Inc